abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
94810: Hiv-1 Resistance And Coreceptor Tropism, Proviral Dna Print View
HIV-1 PR, RT Proviral DNA      
HIV-1 Integrase Proviral DNA      
CXCR4(X4)      
Net Tropism Assessment      
MVC Activity Anticipated      

PRIMARY
1 Whole Blood EDTA 3 (1.2) mL   Frozen - 28 Day(s)/Refrigerated - 7 Day(s)/Room Temperature - 7 Day(s)  
ALTERNATE

This panel will assist clinicians to evaluate virologically suppressed patients for antiretroviral regimen modification when there is insufficient historical viral RNA resistance and viral tropism information. This test utilizes PCR and next generation (ultra-deep) sequencing of proviral DNA to detect drug resistance mutations in the HIV-1 protease, reverse transcriptase and integrase genes. As the CCR5 antagonist maraviroc may also be considered as a component of a new regimen, this panel includes the requisite tropism test performed on proviral DNA.
Setup Schedule
Tuesday, Saturday

Reported (Analytical Time)
4 days

CPT Codes
87901,87900,87906x2

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Methodology: Polymerase Chain Reaction and Next Generation (ultra-deep) Sequencing
Transport Temperature: Room Temperature






1996 - 2019 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database